Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Circulation

Showing results (1611-1620 of 25,675) with videos related to

Pageof 2,568
Sort By:
Circulation|April 28, 2010
Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammationPeter I Bonta, Thijs W H Pols, Claudia M van Tiel, et al.
Circulation|March 31, 2010
Elevated cytosolic Na+ increases mitochondrial formation of reactive oxygen species in failing cardiac myocytesMichael Kohlhaas, Ting Liu, Andreas Knopp, et al.
Circulation|February 11, 2009
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factorsPeter Collins, Lori Mosca, Mary Jane Geiger, et al.
Circulation|February 11, 2009
Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populationsW H Linda Kao, Dan E Arking, Wendy Post, et al.
Circulation|February 11, 2009
Temporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drug-eluting stent eras: results from the US Medicare programJason Ryan, Walter Linde-Zwirble, Luella Engelhart, et al.
Circulation|June 3, 2009
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosisMartin Unverdorben, Christian Vallbracht, Bodo Cremers, et al.
Circulation|June 3, 2009
Associations of physical activity with inflammatory factors, adipocytokines, and metabolic syndrome in middle-aged and older chinese peopleZhijie Yu, Xingwang Ye, Jing Wang, et al.
Circulation|March 1, 1990
Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertensionW J Elliott, R R Weber, K S Nelson, et al.
Circulation|October 7, 2009
Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter studyFrancesco Violi, Valerio Sanguigni, Roberto Carnevale, et al.
Circulation|June 17, 2009
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel studyMarco Valgimigli, Gianluca Campo, Nicoletta de Cesare, et al.
Pageof 2,568

Showing results (1611-1620 of 25,675) with videos related to

Sort By:
Pageof 2,568
Circulation|April 28, 2010
Nuclear receptor Nurr1 is expressed in and is associated with human restenosis and inhibits vascular lesion formation in mice involving inhibition of smooth muscle cell proliferation and inflammationPeter I Bonta, Thijs W H Pols, Claudia M van Tiel, et al.
Circulation|March 31, 2010
Elevated cytosolic Na+ increases mitochondrial formation of reactive oxygen species in failing cardiac myocytesMichael Kohlhaas, Ting Liu, Andreas Knopp, et al.
Circulation|February 11, 2009
Effects of the selective estrogen receptor modulator raloxifene on coronary outcomes in the Raloxifene Use for The Heart trial: results of subgroup analyses by age and other factorsPeter Collins, Lori Mosca, Mary Jane Geiger, et al.
Circulation|February 11, 2009
Genetic variations in nitric oxide synthase 1 adaptor protein are associated with sudden cardiac death in US white community-based populationsW H Linda Kao, Dan E Arking, Wendy Post, et al.
Circulation|February 11, 2009
Temporal changes in coronary revascularization procedures, outcomes, and costs in the bare-metal stent and drug-eluting stent eras: results from the US Medicare programJason Ryan, Walter Linde-Zwirble, Luella Engelhart, et al.
Circulation|June 3, 2009
Paclitaxel-coated balloon catheter versus paclitaxel-coated stent for the treatment of coronary in-stent restenosisMartin Unverdorben, Christian Vallbracht, Bodo Cremers, et al.
Circulation|June 3, 2009
Associations of physical activity with inflammatory factors, adipocytokines, and metabolic syndrome in middle-aged and older chinese peopleZhijie Yu, Xingwang Ye, Jing Wang, et al.
Circulation|March 1, 1990
Renal and hemodynamic effects of intravenous fenoldopam versus nitroprusside in severe hypertensionW J Elliott, R R Weber, K S Nelson, et al.
Circulation|October 7, 2009
Hereditary deficiency of gp91(phox) is associated with enhanced arterial dilatation: results of a multicenter studyFrancesco Violi, Valerio Sanguigni, Roberto Carnevale, et al.
Circulation|June 17, 2009
Intensifying platelet inhibition with tirofiban in poor responders to aspirin, clopidogrel, or both agents undergoing elective coronary intervention: results from the double-blind, prospective, randomized Tailoring Treatment with Tirofiban in Patients Showing Resistance to Aspirin and/or Resistance to Clopidogrel studyMarco Valgimigli, Gianluca Campo, Nicoletta de Cesare, et al.
Pageof 2,568